Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Payables (2016 - 2025)

Historic Payables for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $5.3 million.

  • Mesa Laboratories' Payables fell 859.58% to $5.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 million, marking a year-over-year decrease of 859.58%. This contributed to the annual value of $5.7 million for FY2025, which is 486.67% down from last year.
  • According to the latest figures from Q4 2025, Mesa Laboratories' Payables is $5.3 million, which was down 859.58% from $5.1 million recorded in Q3 2025.
  • Over the past 5 years, Mesa Laboratories' Payables peaked at $7.9 million during Q1 2022, and registered a low of $4.0 million during Q2 2021.
  • For the 5-year period, Mesa Laboratories' Payables averaged around $5.9 million, with its median value being $5.7 million (2024).
  • In the last 5 years, Mesa Laboratories' Payables surged by 14098.27% in 2021 and then tumbled by 3783.92% in 2023.
  • Quarter analysis of 5 years shows Mesa Laboratories' Payables stood at $7.8 million in 2021, then fell by 19.66% to $6.3 million in 2022, then decreased by 27.58% to $4.6 million in 2023, then increased by 26.2% to $5.7 million in 2024, then decreased by 8.6% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q4 2025, $5.1 million for Q3 2025, and $6.3 million during Q2 2025.